Recurrent Glioblastoma: Combination of High Cerebral Blood Flow with MGMT Promoter Methylation Is Associated with Benefit from Low-Dose Temozolomide Rechallenge at First Recurrence

替莫唑胺 医学 脑血流 内科学 肿瘤科 队列 放射治疗 胶质母细胞瘤 回顾性队列研究 甲基转移酶 磁共振成像 甲基化 癌症研究 放射科 化学 基因 生物化学
作者
Cherry Kim,Ho Sung Kim,Woo Hyun Shim,Choong Gon Choi,Sang Joon Kim
出处
期刊:Radiology [Radiological Society of North America]
卷期号:282 (1): 212-221 被引量:9
标识
DOI:10.1148/radiol.2016152152
摘要

Purpose To determine if the combination of high cerebral blood flow (CBF) and O6-methylguanine DNA methyltransferase (MGMT) promoter methylation is associated with benefit from a second round of low-dose temozolomide (TMZ) (ie, rechallenge) in patients with glioblastoma at first recurrence. Materials and Methods The institutional review board approved this retrospective cohort study and waived the requirement for informed consent. Seventy-two patients with recurrent glioblastoma after concurrent TMZ radiation therapy were treated with a low-dose TMZ rechallenge and underwent arterial spin labeling magnetic resonance imaging. The cohort was dichotomized to high-CBF and low-CBF subgroups. MGMT promoter methylation was determined before concurrent TMZ radiation therapy. The coprimary end points were median time to progression (TTP) and 6-month outcome after the initiation of low-dose TMZ. The Cox proportional hazards model was used to assess the association between clinical outcome and CBF status. Results There was a significant difference between the high- and low-CBF cohorts in median TTP (6 months vs 3 months, respectively; P = .001). Favorable 6-month outcomes occurred in 16 of 31 (52%) patients with high CBF and six of 41 (15%) patients with low CBF (P = .001). At multivariate analysis, high CBF was independently associated with longer TTP (P = .023). The association between high CBF and favorable outcome was significant only in the MGMT promoter methylation group (P = .006 for TTP; P = .005 for 6-month outcome). Conclusion The combination of high CBF with MGMT methylation may be associated with benefits from a low-dose TMZ rechallenge in patients with recurrent glioblastoma. However, alternative strategies might be needed for patients with both low CBF and a lack of MGMT methylation. © RSNA, 2016 Online supplemental material is available for this article.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
打打的应助被幽默的听莲采纳,获得10
1秒前
1秒前
1秒前
大尾巴鱼发布了新的文献求助10
1秒前
2秒前
康舟发布了新的文献求助10
2秒前
BOBO发布了新的文献求助10
2秒前
自由完成签到 ,获得积分10
3秒前
tongtong发布了新的文献求助10
3秒前
susuw发布了新的文献求助10
3秒前
3秒前
爆米花的应助被高风亮节的人采纳,获得10
4秒前
笨笨山芙的应助被JanaL采纳,获得10
6秒前
地形图发布了新的文献求助10
6秒前
东风的应助被咖啡不加糖采纳,获得10
6秒前
zero完成签到,获得积分10
7秒前
哈哈哈完成签到,获得积分10
7秒前
传奇3的应助被You采纳,获得10
7秒前
feng完成签到,获得积分10
7秒前
8秒前
8秒前
8秒前
9秒前
阿克图尔斯·蒙斯克完成签到,获得积分10
9秒前
彭于晏的应助被单薄谷秋采纳,获得10
9秒前
大尾巴鱼完成签到,获得积分20
11秒前
娜娜子欧完成签到,获得积分10
11秒前
爆米花的应助被hql_sdu采纳,获得10
12秒前
letgo发布了新的文献求助10
13秒前
悦耳的城发布了新的文献求助10
13秒前
桐桐的应助被奋斗花生采纳,获得10
14秒前
tina发布了新的文献求助10
14秒前
suodeheng完成签到,获得积分10
14秒前
虚心曼易完成签到 ,获得积分10
15秒前
thebin完成签到,获得积分10
16秒前
阿豪完成签到,获得积分10
16秒前
17秒前
地形图完成签到,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193514
求助须知:如何正确求助?哪些是违规求助? 9579686
关于积分的说明 21866883
捐赠科研通 7793152
什么是DOI,文献DOI怎么找? 3437297
关于科研通互助平台的介绍 2560725
邀请新用户注册赠送积分活动 2484176